Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer

Autor: Paccagnella, A., Favaretto, A., Oniga, F., Barbieri, F., Ceresoli, G., Torri, W., Villa, E., Verusio, C., Cetto, Gianluigi, Santo, A., Depangher, V., Artioli, F., Cacciani, G. C., Paroli, G., Soresi, F., Ghi, M. G., Morabito, A., Biason, R., Giusto, M., Mosconi, P., Chiarion Sileni, V.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1943::2df4031b421c4822a182f41d4a83f91d
http://hdl.handle.net/11562/23574

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.

Autor: Paccagnella A; Department of Medical Oncology, SS Giovanni and Paolo Hospital, Campo S Giovanni e Paolo, 30100 Venice, Italy. Adriano@ulss12.ve.it, Favaretto A, Oniga F, Barbieri F, Ceresoli G, Torri W, Villa E, Verusio C, Cetto GL, Santo A, De Pangher V, Artioli F, Cacciani GC, Parodi G, Soresi F, Ghi MG, Morabito A, Biason R, Giusto M, Mosconi P, Chiarion Sileni V

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2004 Jan; Vol. 43 (1), pp. 83-91.

Values and limits of combined use of 4 tumor markers (CEA, TPA, NSE and SCC) in un-treated patients with lung cancer.

Autor: Cuomo A; Clinic of Respiratory Disease, University of Parma., Capra R, Greco S, Cacciani GC, Greco F, Franchini D, Bonelli P, Gavaruzzi G, Ugolotti G

Publikováno v: Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma [Acta Biomed Ateneo Parmense] 1993; Vol. 64 (5-6), pp. 171-84.